New tool aims to help pregnant women navigate genetic testing decisions

NCT ID NCT03420274

Completed Knowledge-focused Sponsor: The Cleveland Clinic Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a shared decision-making tool called NEST to help pregnant women understand and choose noninvasive prenatal testing (NIPT). Over 600 pregnant women participated, comparing those who used the tool with those who received usual care. The goal was to see if the tool improved informed decision-making about genetic screening.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: shared decision-making tool (NEST)
What this could lead to: If successful, this could improve how doctors and patients discuss prenatal genetic testing, leading to more informed choices.
What could go wrong: This is a behavioral study, not a treatment trial. Results may not apply to all clinics or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENETIC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hereditary disease pregnancy disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GENETIC DISEASE GENETIC SYNDROME PREGNANCY COMPLICATIONS PRENATAL DISORDER PRENATAL MATERNAL ABNORMALITY

New tool aims to help pregnant women navigate genetic testing decisions

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions